Trifecta Capital Advisors, LLC Ark Genomic Revolution ETF (De Transaction History
Trifecta Capital Advisors, LLC
- $478 Billion
- Q3 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 465 shares of ARKG stock, worth $12,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
465
Previous 465
-0.0%
Holding current value
$12,090
Previous $10.9 Million
9.02%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
288Shares Held
22.4MCall Options Held
2.79MPut Options Held
6.56M-
Jpmorgan Chase & CO New York, NY2.96MShares$76.8 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.75MShares$71.6 Million3.23% of portfolio
-
Ubs Group Ag1.75MShares$45.4 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$43.7 Million0.03% of portfolio
-
Morgan Stanley New York, NY1.54MShares$40 Million0.0% of portfolio